FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

40733711000001106: Motusol Max 2.32% gel (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jul 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2263821000001118 Motusol Max 2.32% gel (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2263841000001111 Motusol Max 2.32% gel (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Motusol Max 2.32% gel (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has excipient Fragrances false Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Is a Diclofenac diethylammonium 2.32% gel true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Is a Motusol true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Diclofenac sodium true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) Has specific active ingredient Diclofenac diethylammonium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Motusol Max 2.32% gel (Teva UK Ltd) 50 gram Has AMP True Motusol Max 2.32% gel (Teva UK Ltd) Inferred relationship Existential restriction modifier
Motusol Max 2.32% gel (Teva UK Ltd) 30 gram Has AMP True Motusol Max 2.32% gel (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start